Lv4
516 积分 2025-09-09 加入
Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women
13天前
已完结
[Our experience with management of inherited thrombophilia during pregnancy. Preliminary report]
13天前
已关闭
Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review
13天前
已完结
Emerging pharmacotherapies for androgenetic alopecia
28天前
已完结
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1
29天前
已完结
OVEPOREXTON (TAK-861) FOR THE TREATMENT OF NARCOLEPSY TYPE 1: EFFICACY AND SAFETY RESULTS FROM TWO PIVOTAL PHASE 3 TRIALS
30天前
已完结
Emerging pharmacotherapies for androgenetic alopecia
1个月前
已完结
Effects of Oveporexton, an Orexin Receptor 2–Selective Agonist, on Cognition in Narcolepsy Type 1
1个月前
已完结
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1
1个月前
已完结
Benefits of oveporexton in narcolepsy type 1
1个月前
已完结
皖公网安备34019202002308
